Evidence map›Paper›PMID 24919409›Full record

ArticleActa paediatrica (Oslo, Norway : 1992)2014

Arginase I gene single-nucleotide polymorphism is associated with decreased risk of pulmonary hypertension in bronchopulmonary dysplasia.

J K Trittmann, L D Nelin, E J Zmuda, J M Gastier-Foster, B Chen, C H Backes, J Frick, P Vaynshtok, V J Vieland, M A Klebanoff

Abstract read
In one paragraph

Article in Acta paediatrica (Oslo, Norway : 1992), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Bronchopulmonary dysplasia and pulmonary hypertension: a meta-analysis.Journal of perinatology : official journal of the California Perinatal Association · 2017
    Pooled it
  3. Article
  4. Review
  5. Article
  6. Pulmonary hypertension in the newborn- etiology and pathogenesis.Seminars in fetal & neonatal medicine · 2022
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

J K TrittmannOhio Perinatal Research Network, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA; Pulmonary Hypertension Group, Center for Perinatal Research, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA; Department of Pediatrics, The Ohio State University, Columbus, OH, USA.
L D Nelin
E J Zmuda
J M Gastier-Foster
B Chen
C H Backes
J Frick
P Vaynshtok
V J Vieland
M A Klebanoff
The Ohio State University · USNationwide Children's Hospital · USResearch Network (United States) · US

Funding

The Ohio State University Center for clinical and Translational ScienceUL1TR001070 · NCATS · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2013 to 2017
$22.6M
Novel therapeutic targets for bronchopulmonary dysplasia-associated pulmonary hypertensionK08HL129080 · NHLBI · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI TRITTMANN, JENNIFER K · 2016 to 2020
$768k
Regulation of Arginase in Models of Pulmonary HypertensionK08HL105677 · NHLBI · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI CHEN, BERNADETTE · 2011 to 2015
$633k
Intramural NIH HHSNCATS NIH HHS UL1 TR001070NCATS NIH HHS UL1TR001070NHLBI NIH HHS K08 HL105677NHLBI NIH HHS K08 HL129080
6 · The paper itself

Abstract

aimTo test the hypothesis that there are single-nucleotide polymorphisms (SNPs) in genes of the l-arginine/nitric oxide pathway associated with pulmonary hypertension (PH) in neonates with bronchopulmonary dysplasia (BPD).

methodsNeonates with BPD were enrolled (n = 140) and clinical characteristics compared between case (BPD + PH) and control (BPD) groups. DNA was isolated from blood leucocytes and assayed for 17 SNPs in l-arginine/nitric oxide pathway genes by Sequenom massarray. Genes included carbamoyl-phosphate synthetase, ornithine transcarbamylase, argininosuccinate synthase, nitric oxide synthase and arginase. SNPs were selected from the National Center for Biotechnology Information database for their putative functionality. Calculated minor allele frequencies (MAF) of cases and controls were compared using χ2 and logistic regression.

resultsOf the 140 patients with BPD, 26% had echocardiographic evidence of PH. Ventilation days were longer for cases than controls (mean 31 vs. 15 days, p < 0.05). Of the 17 SNPs, rs2781666 in arginase I gene was less common in cases (MAF = 0.23) than controls (MAF = 0.37, p = 0.04). The odds of PH decreased by 43% (p = 0.047) for each copy of the SNP minor allele in arginase I gene in patients with BPD.

conclusionArginase I SNP (rs2781666) may be associated with protection against pulmonary hypertension in preterm neonates with BPD.

Indexed as

ArginaseBronchopulmonary DysplasiaCase-Control StudiesFemaleHumansHypertension, PulmonaryInfant, NewbornInfant, PrematureMalePolymorphism, Single NucleotideARG1 protein, humanArginasearginineargininosuccinate synthasecarbamoyl-phosphate synthetasenitric oxide synthaseornithine transcarbamylase

Identifiers

PMID24919409
PMCPMC4180790
OpenAlexW1991163266

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.